Role of Mahapaishachik Ghrita in the management of Autism in children

A clinical trial to evaluate the role of Mahapaishachik Ghrita in the management of ASD (Autism Spectrum Disorder) in children - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/05/067708

Enrollment

Registered

2024-05-21

Start date

Unknown

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F840- Autistic disorder

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children aged between 3-12 years of age with clinical features of Autism Spectrum Disorder. 2. Children already diagnosed with ASD and verified with INCLEN parameter. 3. Parents willing to give informed written consent to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Children not fulfilling the screening criteria for diagnosis of ASD. 2. Children of severe psychotic illness like oppositional defiant disorders, conduct disorders 3. Children on psychiatric treatment. 4. Children with chronic ailments like tuberculosis, malignancy etc.

Design outcomes

Primary

Measure	Time frame
1.Improvement in quality of life of children. 2. Improvement in Speech/ Language communication, Sociability, Sensory/ Cognitive Awareness, Health awareness. Timepoint: After 30 days of complete clinical trial.	—

Secondary

Measure	Time frame
To evaluate the efficacy of the Mahapaishachik GhritaTimepoint: 1st day, 30th day, 45th day, 75th day, 90th day, 120th day,	—

Countries

India

Contacts

Public ContactDr Laxmi

State Ayurvedic college and hospital Lucknow

lakshmiomsingh@gmail.com9792446688

Outcome results